EUVIMEDEUVIMED entdecken
Open Access

Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma

Lin Chen iD, Siyuan Liu, Dickson Adah, Qingyang Sun, Zhaoduan Liang, Mitchell Ho, Beicheng Sun

Immunology · 2023-06 · 169 (2) · 204-218

DOI: 10.1111/imm.13624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, online erschienen am 25.01.2023. Verfasst von Lin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Rep…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Receptors, Chimeric Antigen, Liver Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the pre‐clinical study of chimeric antigen receptor (CAR)‐natural killer (NK) cell was effective against various tumours, immunosuppression mediated by tumour microenvironment hampers their application and several efforts have been explored to improve their effect in combating solid tumours. Glypican 3 (GPC3) is a promising target for hepatocellular carcinoma (HCC), and CAR‐T cells targeting GPC3 have been tested in clinical trials. Based on an affinity‐enhanced antibody (hYP7) targeting GPC3, we constructed GPC3‐CAR‐NK cells to explore their potential function in the treatment of HCC. We found that patients with HCC secreted high levels of soluble programmed death‐ligand 1 (sPD‐L1), which inhibits the function of CAR‐NK cells targeting GPC3. In addition, we combined high‐affinity sPD‐L1 variant (L3C7c‐Fc) with GPC3‐CAR‐NK cells to solve the problem of GPC3‐CAR‐NK inhibition. Our studies demonstrated that L3C7c‐Fc could enhance the therapeutic effect of CAR‐NK cells by reversing the suppression of sPD‐L1, which provides the experimental evidence for the subsequent development of HCC immunotherapy strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularReceptors, Chimeric AntigenLiver NeoplasmsHumansGlypicansKiller Cells, NaturalTumor MicroenvironmentB7-H1 Antigen

Stichwörter der Autor:innen

CAR-NK cellsPD-1sPD-L1tumour microenvironment

Substanzen

Receptors, Chimeric AntigenGlypicansCD274 protein, humanB7-H1 AntigenGPC3 protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Republic of China.
  • Department of Hepatobiliary surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, People's Republic of China.
  • State Key Laboratory of Respiratory Disease, Center of Infection and Immunity, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Science, Guangzhou, People's Republic of China.
  • Department of Pathology, Affiliated Drum Tower Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
  • Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

ORCID-Profile: Lin Chen

Förderung

  • Intramural NIH HHS

Zitieren

APA

Chen, L., Liu, S., Adah, D., Sun, Q., Liang, Z., Ho, M., & Sun, B. (2023). Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma. Immunology, 169(2), 204-218. https://doi.org/10.1111/imm.13624

Vancouver

Chen L, Liu S, Adah D, Sun Q, Liang Z, Ho M, et al. Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma. Immunology. 2023;169(2):204-218. doi:10.1111/imm.13624

BibTeX
@article{Chen2023,
  author = {Chen, Lin and Liu, Siyuan and Adah, Dickson and Sun, Qingyang and Liang, Zhaoduan and Ho, Mitchell and Sun, Beicheng},
  title = {Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma},
  journal = {Immunology},
  year = {2023},
  volume = {169},
  number = {2},
  pages = {204--218},
  doi = {10.1111/imm.13624}
}
Kostenlos starten →